• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

ALS/MND Health Literacy Map

A Framework for Health Literacy and Increasing Quality of Life

The ALS/MND Health Literacy Map is a framework designed to support people living with ALS/MND (PALS) and their communities (CALS) in understanding the disease, navigating care, and improving quality of life.

Preview of the ALS/MND Health Literacy Map. The full framework includes topics like understanding the disease, living with it, treatment, and advocacy.

It covers the many topics that individuals and their loved ones need to know when faced with an ALS/MND diagnosis. At the heart of this initiative are the people living with ALS/MND and their communities, who inform us with the unique perspective of lived experience.

This tool brings together a wide range of interconnected topics, organized across four key areas:

  • Understanding ALS/MND
  • Living with ALS/MND
  • Treating ALS/MND
  • Taking Action

Download the Health Literacy Map

This full framework is available as a PDF: 📄Download the Health Literacy Map.

Why Health Literacy Matters

Health literacy means having the ability to obtain, understand, and use health information and services to make informed decisions about one’s health and well-being. For PALS and CALS, this knowledge empowers participation in care decisions and advocacy for their needs.

This map will help the Alliance:

  • Identify opportunity gaps and guide future educational initiatives
  • Inform updates to our website, programs, and resources
  • Ensure information is accessible, inclusive, and available globally
  • Encourage collaboration and avoid duplication of effort across our community

This framework is shaped by key values that guide how we interpret and share information:

  • Human-centric: inclusive, empathetic, and person-first
  • Global: universally relevant, regardless of geography
  • Transparent: open, collaborative, and community-informed
  • Accessible: easy to consume, in multiple formats and languages

We hope this resource supports not just individuals and families, but also our wider ecosystem of healthcare professionals, researchers, industry partners, and Alliance members.

Acknowledgements

This project was developed by the ALS/MND Health Literacy Task Force and supported by a generous group of sponsors and expert contributors. We thank everyone who helped bring this framework to life.

Primary Sidebar

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Debbie Craghill, USA

    Debbie Craghill, USA

  • Daniela Maria Daverio, Argentina

    Daniela Maria Daverio, Argentina

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Andrea Zicchieri, Italy

    Andrea Zicchieri, Italy
    AndreaZicchieri_conSLAncioItaly

  • David Watson, Scotland

    David Watson, Scotland

  • Art Eggert, USA

    Art Eggert, USA

  • Ian Gale, Australia

    Ian Gale, Australia

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • John Dinon, Australia

    John Dinon, Australia

  • Carlos Alberto Báez Murillo, Colombia

    Carlos Alberto Báez Murillo, Colombia

  • Frank Bos, Netherlands

    Frank Bos, Netherlands

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Jo Knowlton, Scotland

    Jo Knowlton, Scotland

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • John Russo, USA

    John Russo, USA
    final3878

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Michel Perrozzo, France

    Michel Perrozzo, France

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Liam Dwyer, England

    Liam Dwyer, England

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • Timmy, Belgium

    Timmy, Belgium

  • Sally Pauls, USA

    Sally Pauls, USA

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Bayley, Australia

    Bayley, Australia

  • Philip Brindle, England

    Philip Brindle, England

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Anita Forte, USA

    Anita Forte, USA

  • Jason Goodman, USA

    Jason Goodman, USA

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Jean Waters, UK

    Jean Waters, UK

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login